Congenital myasthenic syndromes: New insights from molecular genetic and patch-clamp studies

Annals of the New York Academy of Sciences

Volumn 841, Issue , 1998, Pages 140-156

  Engel, Andrew G ^a   Ohno, Kinji ^a   Milone, Margherita ^a   Sine, Steven M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; RECEPTOR SUBUNIT;

APOPTOSIS; CLINICAL FEATURE; CONFERENCE PAPER; CONSENSUS SEQUENCE; DEPOLARIZATION; GENE MUTATION; GENETIC HETEROGENEITY; HUMAN; MUSCLE WEAKNESS; MYASTHENIA; NEUROMUSCULAR SYNAPSE; PROTEIN DOMAIN; PROTEIN FOLDING; RECESSIVE GENE;

EID: 0031927907     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10921.x     Document Type: Article

References (52)

1. ENGEL, A. G. 1994. Myasthenic syndromes. In Myology: Basic and Clinical, p. 1798-1835. McGraw-Hill. New York.
2. ENGEL, A. G. 1993. The investigation of congenital myasthenic syndromes. Ann. N.Y. Acad. Sci. 681: 425-434.
3. ENGEL, A. G., E. H. LAMBERT, D. M. MULDER, C. F. TORRES, K. SAHASHI, T. E. BERTORINI & J. N. WHITAKER. 1982. A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel. Ann. Neurol. 11: 553-569.
4. ENGEL, A. G., E. H. LAMBERT & M. R. GOMEZ. 1977. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetyl-choline release. Ann. Neurol. 1: 315-330.
5. HUTCHINSON, D. O., T. J. WALLS, S. NAKANO, S. CAMP, P. TAYLOR, C. M. HARPER, R. V. GROOVER, H. A. PETERSON, D. G. JAMIESON & A. G. ENGEL. 1993. Congenital endplate acetylcholinesterase deficiency. Brain 116: 633-653.
6. MORA, M., E. H. LAMBERT & A. G. ENGEL. 1987. Synaptic vesicle abnormality in familial infantile myasthenia. Neurology 37: 206-214.
7. ENGEL, A. G. & E. H. LAMBERT. 1987. Congenital myasthenic syndromes. Electroencephalogr. Clin. Neurophysiol. Suppl. 39: 91-102.
8. MILONE, M., D. O. HUTCHINSON & A. G. ENGEL. 1994. Patch-clamp analysis of the properties of acetylcholine receptor channels at the normal human endplate. Muscle Nerve 17: 1364-1369.
9. OHNO, K., D. O. HUTCHINSON, M. MILONE, J. M. BRENGMAN, C. BOUZAT, S. M. SINE & A. G. ENGEL. 1995. Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the ε subunit. Proc. Natl. Acad. Sci. U.S.A. 92: 758-762.
10. SINE, S. M., K. OHNO, C. BOUZAT, A. AUERBACH, M. MILONE, J. N. PRUITT & A. G. ENGEL. 1995. Mutation of the acetylcholine receptor α subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron 15: 229-239.
11. ENGEL, A. G., K. OHNO, M. MILONE, H-L. WANG, S. NAKANO, C. BOUZAT, J. N. PRUITT, D. O. HUTCHINSON, J. M. BRENGMAN, N. BREN et al. 1996. New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum. Mol. Genet. 5: 1217-1227.
12. MILONE, M., H-L. WANG, K. OHNO, T. FUKUDOME, J. N. PRUITT, N. BREN, S. M. SINE & A. G. ENGEL. 1997. Slow-channel syndrome caused by enhanced activation, desensitization, and agonist binding affinity due to mutation in the M2 domain of the acetylcholine receptor alpha subunit. J. Neurosci. 17: 5651-5665.
13. OHNO, K., P. QUIRAM, M. MILONE, H-L. WANG, C. M. HARPER, J. N. PRUITT, J. M. BRENGMAN, L. PAO, K. H. FISCHBECK, T. O. CRAWFORD, S. M. SINE & A. G. ENGEL. 1997. Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor ε subunit gene: identification and functional characterization of six new mutations. Hum. Mol. Genet. 6: 753-766.
14. OHNO, K., H-L. WANG, M. MILONE, N. BREN, J. M. BRENGMAN, S. NAKANO, P. QUIRAM, J. N. PRUITT, S. M. SINE & A. G. ENGEL. 1996. Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor ε subunit. Neuron 17: 157-170.
15. OHNO, K., A. G. ENGEL, M. MILONE, J. M. BRENGMAN, J. P. SIEB & IANNACCONE. 1995. A congenital myasthenic syndrome with severe acetylcholine receptor deficiency caused by heteroallelic frameshifting mutations in the epsilon subunit. Neurology 45(suppl. 4): A283.
16. MILONE, M., K. OHNO, J. N. PRUITT, J. M. BRENGMAN, S. M. SINE & A. G. ENGEL. 1996. Congenital myasthenic syndrome due to frameshifting acetylcholine receptor epsilon subunit mutation. Soc. Neurosci. Abstr. 22: 1942.
17. OHNO, K., T. FUKUDOME, S. NAKANO, M. MILONE, T. E. FEASBY, G. M. TYCE & A. G. ENGEL. 1996. Mutational analysis in a congenital myasthenic syndrome reveals a novel acetylcholine receptor epsilon subunit mutation. Soc. Neurosci. Abstr. 22: 234.
18. ENGEL, A. G., K. OHNO, C. BOUZAT, S. M. SINE & R. G. GRIGGS. 1996. End-plate acetylcholine receptor deficiency due to nonsense mutations in the ε subunit. Ann. Neurol. 40: 810-817.
19. MILONE, M., K. OHNO, T. FUKUDOME, X-M. SHEN, J. BRENGMAN, R. C. GRIGGS & A. G. ENGEL. 1998. Congenital myasthenic syndrome caused by novel loss of function mutations in the human AChR ε subunit gene. This volume.
20. OHNO, K., B. ANLAR, E. ÖZDIRION, J. M. BRENGMAN & A. G. ENGEL. 1998. Frameshifting and splice-site mutations in acetylcholine receptor E subunit gene in three Turkish kinships with congenital myasthenic syndromes. This volume.
21. SANDROCK, A. W, S. E. DRYER, K. M. ROSEN, S. M. GOZANI, R. KRAMER, L. E. THEILL & G. D. FISCHBACH. 1997. Maintenance of acetylcholine receptor number by neuregulins at the neuromuscular junction in vivo. Science 276: 599-603.
22. TANSEY, M. G., G. C. CHU & J. P. MERLIE. 1996. ARIA/HRG regulates AChR epsilon subunit gene expression at the neuromuscular synapse via activation of phosphatidylinositol 3-kinase and RAS/MAPK pathway. J. Cell Biol. 134: 465-476.
23. SI, J., Z. LUO & L. MEI. 1996. Induction of acetylcholine receptor gene expression by ARIA requires activation of mitogen-activated protein kinase. J. Biol. Chem. 271: 19752-19759.
24. GAUTAM, M., P. G. NOAKES, L. MOSCOSO, F. RUPP, R. H. SCHELLER, J. P. MERLIE & J. R. SANES. 1996. Defective neuromuscular synaptogenesis in agrin-deficient mutant mice. Cell 85: 525-535.
25. DECHIARA, T. M., D. C. BOWEN, D. M. VALENZUELA, M. V SIMMONS, W. T. POUEYMIROU, S. THOMAS, E. KINETZ, D. L. COMPTON, E. ROJAS, J. S. PARK et al. 1996. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 85: 501-512.
26. GLASS, D. J., D. C. BOWEN, T. N. STITT, C. RADZIEJEWSKI, J. BRUNO, T. E. RYAN, D. R. GIES, H. SHAH, K. MATTSON, S. J. BURDEN et al. 1996. Agrin acts via MuSK receptor complex. Cell 85: 513-523.
27. GAUTAM, M., P. G. NOAKES, J. MUDD, M. NICHOL, G. C. CHU, J. R. SANES & J. P. MERLIE. 1995. Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice. Nature 377: 232-236.
28. PHILLIPS, W. D. 1995. Acetylcholine receptors and the cytoskeletal connection. Clin. Exp. Pharmacol. Physiol. 22: 961-965.
29. DECONINCK, A. E., A. C. POTTER, J. M. TINSLEY, S. J. WOOD, R. VATER, C. YOUNG, L. METZINGER, A. VINCENT, C. R. SLATER & K. E. DAVIES. 1997. Postsynaptic abnormalities at the neuromuscular junction of utrophin-deficient mice. J. Cell Biol. 136: 883-894.
30. GRADY, R. M., J. P. MERLIE & J. R. SANES. 1997. Subtle neuromuscular defects in utrophin-deficient mice. J. Cell Biol. 136: 871-882.
31. ENGEL, A. G., K. OHNO, M. MILONE & S. M. SINE. 1997. Congenital myasthenic syndromes caused by mutations in acetylcholine receptor genes. Neurology 48(suppl. 5): S28-S35.
32. OHNO, K., D. O. HUTCHINSON, M. MILONE, S. NAKANO, J. P. SIEB, J. M. BRENGMAN & A. G. ENGEL. 1995. Molecular genetic basis of a slow-channel syndrome. Muscle Nerve 18: 463 (abstract).
33. WANG, H-L., A. AUERBACH, N. BREN, K. OHNO, A. G. ENGEL & S. M. SINE. 1997. Mutation in the Ml domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation. J. Gen. Physiol. 109: 757-766.
34. GOMEZ, C. M., R. MASELLI, J. GAMMACK, J. LASALDE, S. TAMAMIZU, D. R. CORNBLATH, M. LEHAR, M. MCNAMEE & R. KUNCL. 1996. A beta-subunit mutation in the acetylcholine receptor gate causes severe slow-channel syndrome. Ann. Neurol. 39: 712-723.
35. CROXEN, R., C. NEWLAND, D. BEESON, H. OOSTERHUIS, G. CHAUPLANAZ, A. VINCENT & J. NEWSOM-DAVIS. 1997. Mutations in different functional domains of the human muscle acetylcholine receptor a subunit in patients with the slow-channel congenital myasthenic syndrome. Hum. Mol. Genet. 6: 767-773.
36. GOMEZ, C. M. & J. T. GAMMACK. 1995. A leucine-to-phenylalanine substitution in the acetylcholine receptor ion channel in a family with the slow-channel syndrome. Neurology 45: 982-985.
37. MASELLI, R. A. & C. LEUNG. 1993. Analysis of anticholinesterase-induced neuromuscular transmission failure. Muscle Nerve 16: 548-553.
38. UCHITEL, O., A. G. ENGEL, T. J. WALLS, A. NAGEL, Z. M. ATASSI & V. BRIL. 1993. Congenital myasthenic syndromes. II. A syndrome attributed to abnormal interaction of acetylcholine with its receptor. Muscle Nerve 16: 1293-1301.
39. HESSELMANS, L. F. G. M., F. G. I. JENNEKENS, C. J. M. VAN DEN OORD, H. VELDMAN & A. VINCENT. 1993. Development of innervation of skeletal muscle fibers in man: relation to acetylcholine receptors. Anat. Rec. 236: 553-562.
40. WITZEMANN, V., H. SCHWARTZ, M. KOENEN, C. BERBERICH, A. VILLARROEL, A. WERNIG, H. R. BRENNER & B. SAKMANN. 1996. Acetylcholine receptor epsilon subunit deletion causes muscle weakness and atrophy in juvenile and adult mice. Proc. Natl. Acad. Sci. U.S.A. 93: 13286-13291.
41. VILLARROEL, A. & B. SAKMANN. 1996. Calcium permeability increase of endplate channels in rat muscle during postnatal development. J. Physiol. (Lond.) 496: 331-338.
42. SAKMANN, B., V WITZEMANN & H. BRENNER. 1992. Developmental changes in acetyl-choline receptor channel structure and function as a model for synaptic plasticity. Fidia Res. Found. Neurosci. Award Lect. 6: 51-103.
43. HALL, Z. W. & J. R. SANES. 1993. Synaptic structure and development: the neuromuscular junction. Cell 72(suppl.): 99-121.
44. MOSCOSO, L. M., G. C. CHU, M. GAUTAM, P. G. NOAKES, J. P. MERLIE & J. R. SANES. 1995. Synapse-associated expression of an acetylcholine receptor-inducing protein, ARIA/Heregulin, and its putative receptors, Erb2 and Erb3, in developing mammalian muscle. Dev. Biol. 172: 158-169.
45. PLOMP, J. J., G. T. H. VAN KEMPEN & P. C. MOLENAAR. 1992. Adaptation of quantal content to decreased postsynaptic sensitivity at single endplates in α-bungarotoxin treated rats. J. Physiol. (Lend.) 458: 487-499.
46. PLOMP, J. J., G. T. H. VAN KEMPEN, M. B. DE BAETS, Y. M. F. GRAUS, J. B. M. KUKS & P. C. MOLENAAR. 1995. Acetylcholine release in myasthenia gravis: regulation at single end-plate level. Ann. Neurol. 37: 627-636.
47. LIU, Y. & P. BREHM. 1993. Expression of subunit-omitted mouse nicotinic acetylcholine receptors in Xenopus laevis oocytes. J. Physiol. (Lond.) 470: 349-363.
48. FUKUDOME, T., K. OHNO, J. M. BRENGMAN & A. G. ENGEL. 1997. Quinidine sulfate normalizes the open duration of slow channel congenital myasthenic syndrome acetylcholine receptor channels expressed in human embryonic kidney cells. Neurology 48: A72 (abstract).
49. HARPER, C. M. & A. G. ENGEL. 1997. Quinidine sulfate in the treatment of the slow channel congenital myasthenic syndrome. Neurology 48: A72 (abstract).
50. WALLS, T. J., A. G. ENGEL, A. S. NAGEL, C. M. HARPER & V. F. TRASTEK. 1993. Congenital myasthenic syndrome associated with paucity of synaptic vesicles and reduced quantal release. Ann. N.Y. Acad. Sci. 681: 461-468.
51. CAMP, S., S. BON, Y. LI, D. K. GETMAN, A. G. ENGEL, J. MASSOULIÉ & P. TAYLOR. 1995. Patients with congenital myasthenia associated with end-plate acetylcholinesterase deficiency show normal sequence, mRNA splicing, and assembly of catalytic subunits. J. Clin. Invest. 95: 333-340.
52. ENGEL, A. G., O. UCHITEL, T. J. WALLS, A. NAGEL, C. M. HARPER & J. BODENSTEINER. 1993. Newly recognized congenital myasthenic syndrome associated with high conductance and fast closure of the acetylcholine receptor channel. Ann. Neurol. 34: 38-47.